Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis. - Wikidata - awgldk - TriplyDB

Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis.

Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis.

http://www.wikidata.org/entity/Q46483776

about

HDAC inhibitors as anti-inflammatory agents The many roles of histone deacetylases in development and physiology: implications for disease and therapy Nicotinamide restores cognition in Alzheimer's disease transgenic mice via a mechanism involving sirtuin inhibition and selective reduction of Thr231-phosphotau HDAC Inhibitors as Epigenetic Regulators of the Immune System: Impacts on Cancer Therapy and Inflammatory Diseases Butyrate, neuroepigenetics and the gut microbiome: Can a high fiber diet improve brain health?Nucleolar dysfunction in Huntington's disease The genetics of multiple sclerosis: review of current and emerging candidates Growing the growth cone: remodeling the cytoskeleton to promote axon regeneration FOXP3: genetic and epigenetic implications for autoimmunity Histone deacetylase inhibitors impair the elimination of HIV-infected cells by cytotoxic T-lymphocytes Epigenetic Drugs for Multiple Sclerosis Trichostatin A increases SMN expression and survival in a mouse model of spinal muscular atrophy.Epigenetic mechanisms of neurodegeneration in Huntington's disease Epigenetics in the nervous system Histone deacetylase inhibition decreases cholesterol levels in neuronal cells by modulating key genes in cholesterol synthesis, uptake and efflux Age-dependent epigenetic control of differentiation inhibitors is critical for remyelination efficiency Valproic acid attenuates intercellular adhesion molecule-1 and E-selectin through a chemokine ligand 5 dependent mechanism and subarachnoid hemorrhage induced vasospasm in a rat model.Differential deployment of REST and CoREST promotes glial subtype specification and oligodendrocyte lineage maturation.Histone deacetylase inhibitor ITF2357 is neuroprotective, improves functional recovery, and induces glial apoptosis following experimental traumatic brain injury.Profiling gene expression induced by protease-activated receptor 2 (PAR2) activation in human kidney cells Potent and orally efficacious bisthiazole-based histone deacetylase inhibitors Role of HDAC3 on p53 expression and apoptosis in T cells of patients with multiple sclerosis.Reversal of deficits in dendritic spines, BDNF and Arc expression in the amygdala during alcohol dependence by HDAC inhibitor treatment.Axonal degeneration in multiple sclerosis: can we predict and prevent permanent disability?Post-translational modifications of nucleosomal histones in oligodendrocyte lineage cells in development and disease.Modulation of acetylation: creating a pro-survival and anti-inflammatory phenotype in lethal hemorrhagic and septic shock.Potential of epigenetic therapies in non-cancerous conditions.Histone deacetylase inhibitor suppresses virus-induced proinflammatory responses and type 1 diabetes.The epigenetics of autoimmunity.Histone deacetylase inhibitors for treating a spectrum of diseases not related to cancer The therapeutic potential of HDAC inhibitors in the treatment of multiple sclerosis Histone deacetylase regulation of immune gene expression in tumor cells.Epigenetic approaches to psychiatric disorders.HDAC inhibitor SAHA normalizes the levels of VLCFAs in human skin fibroblasts from X-ALD patients and downregulates the expression of proinflammatory cytokines in Abcd1/2-silenced mouse astrocytes.Epigenetic mechanisms in systemic lupus erythematosus and other autoimmune diseases Genetic and epigenetic underpinnings of sex differences in the brain and in neurological and psychiatric disease susceptibility Regulation of immune responses by histone deacetylase inhibitors Histone deacetylase inhibitor SAHA attenuates post-seizure hippocampal microglia TLR4/MYD88 signaling and inhibits TLR4 gene expression via histone acetylation An integrated approach to design novel therapeutic interventions for demyelinating disorders Trichostatin A Inhibits Epithelial Mesenchymal Transition Induced by TGF-β1 in Airway Epithelium

P2860

Q24564962-EB0DEF30-4138-41E6-A137-3DECC996D3AB Q24628821-2375C93E-3FD6-4148-9682-9547190CE8E7 Q24651880-0C1F1124-EA18-40F9-84D2-8AF6E23F6A49 Q26739120-49064DDA-61D7-4F6A-A2D3-B7745A99E2BB Q26766586-C4115CFA-0BB1-4B4E-ADB9-118E642B82EA Q26822451-965F6BC2-EDE2-4B2B-8FAC-989EF105CB38 Q26825782-20D4DBFE-5314-4D2B-BC76-A93258B0D53C Q26829489-74E19856-BAF0-4F23-9A84-812D18722A93 Q27003398-7197282F-C3BD-49E2-9672-E2968E0AC4B1 Q27324527-D6B5456E-6692-4EB4-A45A-1BCE1DB8EF7E Q28076395-6FA4ADCD-F5FB-4F8B-A326-7583282FB32D Q28289793-23B53AEF-5908-4151-ABE9-6F3E98254AB4 Q28297936-C13F1713-593A-4020-9E9D-DB91BDB598FF Q28300652-6F476CD9-FCA7-47BD-80AB-554C625B14FD Q28484950-8E9B8892-803F-4D8C-B69B-ADB304B13136 Q30052479-AD70BC02-79C7-41EF-B1F2-A27A5A610C2F Q30413642-02E93661-A9C3-4311-BC7C-F6FF3D1D3114 Q33514833-BEE4ACB3-4E04-4F47-AF24-A69B8F3A36D6 Q33613257-531026B6-749C-4A86-B94F-47C3D952C73D Q33745121-19CC84C4-8170-498F-A6B1-D88753BA38AF Q33768549-F0DFB90A-5FF4-4650-9BD7-4463D4B642B3 Q33828002-0D21E759-4A14-4F81-9052-EB093ADD5FF6 Q33887916-ABC53C97-023C-4E20-9760-40E160E3A752 Q34570124-BF2F12BE-355E-4AA9-8B43-E0D6AB07E70F Q34584859-CAE7C11F-BD53-46FA-B73D-A42FB7300EBF Q34635234-B05DFE1E-481E-4C13-9E6E-584F696433CC Q34742578-97C75308-8C41-4004-9E8F-E6B5C0AE37F9 Q34975260-C9E120C5-8B68-4C37-A4A1-B67269322730 Q34979322-AAB4EE38-3E0F-4A4B-A0DC-CF31E26EBBFB Q35016934-B7ECB275-355D-4E36-95B8-84F55D0D4E11 Q35016997-78E1EA70-C2D2-4C05-97FA-2A78D7D37BF2 Q35092304-9FBB1282-C7B3-47E3-B6C9-F400E26CBA53 Q35237163-AD025959-31DB-447B-8806-A9A7EAA7EF51 Q35380239-A66DC8E2-C1FB-4F61-9A7E-342270DD0C12 Q35577576-0CAB072F-5F6B-492B-9106-65FA996400D8 Q35735221-B546685B-5DCA-42D1-A28C-F7C6158A2B7C Q35855571-07169F7A-9951-49C0-B91D-12958E8D6981 Q36021545-4C0F79F9-9340-4434-A5A8-37C5F7B45DC8 Q36059972-9677D5EB-B139-43CF-976C-AEB478EE0943 Q36115999-6CE4D942-9130-4F17-B1D2-518A2FB6AF19

P2860

Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis.

http://www.wikidata.org/entity/Q46483776

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Transcriptional therapy with t ...... autoimmune encephalomyelitis.

@en

Transcriptional therapy with t ...... autoimmune encephalomyelitis.

@nl

type

label

Transcriptional therapy with t ...... autoimmune encephalomyelitis.

@en

Transcriptional therapy with t ...... autoimmune encephalomyelitis.

@nl

prefLabel

Transcriptional therapy with t ...... autoimmune encephalomyelitis.

@en

Transcriptional therapy with t ...... autoimmune encephalomyelitis.

@nl

P1433

Q46483776-464F70B8-342E-4D3E-9AFB-52EAC178F2D4

P1476

Q46483776-83498F97-84D4-4D60-9FCE-F4DE32BD9E58

P2093

Q46483776-06ECB55D-353C-4FC9-932E-165586D9D8C4

Q46483776-0E69D023-8239-496C-B98E-B22A9C8A3F5F

Q46483776-4C33FC53-1D48-48CC-9587-9A2D7CC91A2C

Q46483776-4F8B100D-E7C5-4401-BF42-359EF2A59D92

Q46483776-5FC7288A-53CC-4AAE-B349-10EDB8B47605

Q46483776-668DB3EC-7E20-4C28-A5E8-6E2109D1DA36

Q46483776-72BB51E2-B2A9-4927-8F31-5C93478B966F

Q46483776-9B851575-2EDF-4B4B-A8DB-DD713B73A04A

Q46483776-A530DAAD-39D4-48F1-BF78-4A6301C72CA3

Q46483776-D459CF93-3178-46FF-8E3A-E2AC3E280FE6

P304

Q46483776-6751140B-CAC2-4A0C-83B4-34585CBFBF83

P31

Q46483776-4E16444D-482D-4387-AEF0-F4E227BB1264

P356

Q46483776-C9A7B3ED-D22A-45F5-B318-06A4DDD80B10

P433

Q46483776-24190F84-E784-4B7F-9072-2DCEA73C907A

P478

Q46483776-C8D72E46-AE7A-4F16-B818-7A9690984442

P50

Q46483776-98C6C9EA-E3F3-4BD7-A973-EE6D7ECED6B7

Q46483776-C3FC97F2-9678-40A2-AE99-C1D5B1FCC2DF

Q46483776-EA967BB3-3D38-440E-953B-7B2899DF64CE

P577

Q46483776-F5AB1B24-5BB6-442F-9D7C-681829A0936F

P698

Q46483776-0DF4660B-7467-48EE-9E21-9F5BEAB3D7C1

P921

Q46483776-0D522BCF-33B2-4191-9A0C-2F6E1D01097E

P356

J.JNEUROIM.2005.02.022

P1433

Journal of Neuroimmunology

P1476

Transcriptional therapy with t ...... l autoimmune encephalomyelitis

@en

P2093

Antonio H Iglesias

http://www.w3.org/2001/XMLSchema#string

Basel Assaf

http://www.w3.org/2001/XMLSchema#string

Brice Due

http://www.w3.org/2001/XMLSchema#string

Daehee Hwang

http://www.w3.org/2001/XMLSchema#string

Fernando Dangond

http://www.w3.org/2001/XMLSchema#string

George Stephanopoulos

http://www.w3.org/2001/XMLSchema#string

German Duran

http://www.w3.org/2001/XMLSchema#string

Hoon Ryu

http://www.w3.org/2001/XMLSchema#string

Jaime Imitola

http://www.w3.org/2001/XMLSchema#string

Karen Smith

http://www.w3.org/2001/XMLSchema#string

P304

10-21

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JNEUROIM.2005.02.022

http://www.w3.org/2001/XMLSchema#string

P433

1-2

http://www.w3.org/2001/XMLSchema#string

P478

164

http://www.w3.org/2001/XMLSchema#string

P50

Robert J Ferrante

P577

2005-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15885809

http://www.w3.org/2001/XMLSchema#string

P921

experimental autoimmune encephalomyelitis